Can-Fite BioPharma Ltd.

CANFAMEXHealthcare● Active

$3.08

$-0.01(-0.32%)

Market Cap$1657040

P/E Ratio—

52W High$23.4

52W Low$2.83

Avg Volume519K

Open$3.12

Beta0.01

Overview

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Can-Fite BioPharma Ltd. (CANF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CANF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.90Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)560000.00Full revenue history

Dividend YieldNo DividendDividend history

Shares Outstanding823,926Shares outstanding history

Next EarningsAug 27, 2026Est.Earnings history

Explore Can-Fite BioPharma Ltd. Data

Market Cap$1.7M

Analyst Forecast$5 · Buy

DividendsNo Dividend

Revenue$408212-39.43%

EarningsEPS $-12.03-1013.89%

PE Ratio—

Financial Snapshot

Full Financials

FY 2025Revenue$408212.00▼ 39.43% YoY

202320242025

FY 2025Net Income-$9.9M▼ 25.71% YoY

202320242025

FY 2025EPS$-12.03▼ 1013.89% YoY

202320242025

TTM:Revenue: $560000.00Net Income: -$8.8MEPS: $-0.90View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy4 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$5.00Low

$3.08Current

$5.00Avg Target62.34% upside

$5.00High

Total: 4 · Buy rate: 75.0%

The CANF analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +62.34% upside from the current price of $3.08.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

CANF

Can-Fite BioPharma Ltd.

$3.08-0.32%$1.7M #2

BDRX

Biodexa Pharmaceuticals Plc

$3.38+0.19%$56,618.1 #3

CLDI

Calidi Biotherapeutics, Inc.

$0.17+2.37%$1.3M #4

CMND

Clearmind Medicine Inc.

$3.74-6.28%$3.8M #5

CNSP

CNS Pharmaceuticals, Inc.

Stock Performance

Full History

1D-0.32%

1W-2.53%

1M-12.25%

3M-32.31%

YTD-23.00%

1Y-86.13%

5Y-99.29%

About Can-Fite BioPharma Ltd.

CEOPnina Fishman

IPO DateNov 6, 2012

Employees5

CountryIL

Websitecanfite.com

Can-Fite BioPharma Ltd. a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. Th…

Biotechnology HealthcareAMEXADRIL

About Stock Overview & Key Data

Can-Fite BioPharma Ltd. (CANF) is a Healthcare company in the Biotechnology industry, listed on AMEX since Nov 6, 2012. As of the latest trading session, CANF stock price is $3.08, with a market capitalization of $1.7M. The stock has returned -86.13% over the past 12 months and -23.00% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Can-Fite BioPharma Ltd. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Can-Fite BioPharma Ltd. reported revenue of $408212.00 and net income of -$9.9M. For detailed data — including Can-Fite BioPharma Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Can-Fite BioPharma Ltd. (CANF) stock price is $3.08. The stock is traded on AMEX under the ticker symbol CANF. The 52-week range is $2.83 – $23.40.

CANF stock priceCANF quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice